These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 18496285)

  • 1. Hybrid ventricular assist device: Heartmate XVE LVAD and Abiomed AB5000 RVAD.
    Samuels LE; Shemanski KA; Casanova-Ghosh E; Hagan K; Garwood P; Droogan C
    ASAIO J; 2008; 54(3):332-4. PubMed ID: 18496285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of timing right ventricular assist device withdrawal using left ventricular assist device filling characteristics.
    Mandarino WA; Winowich S; Gasior TA; Pham S; Griffith BP; Kormos RL
    ASAIO J; 1997; 43(5):M801-5. PubMed ID: 9360157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality.
    Morgan JA; John R; Lee BJ; Oz MC; Naka Y
    Ann Thorac Surg; 2004 Mar; 77(3):859-63. PubMed ID: 14992887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right ventricular failure after left ventricular assist device implantation with concomitant pulmonary embolectomy needing right ventricular assist device support in a patient with terminal heart failure and asymptomatic pulmonary thrombus.
    Stepanenko A; Potapov EV; Krabatsch T; Hetzer R
    Interact Cardiovasc Thorac Surg; 2010 Jan; 10(1):154-5. PubMed ID: 19833639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients.
    Ochiai Y; McCarthy PM; Smedira NG; Banbury MK; Navia JL; Feng J; Hsu AP; Yeager ML; Buda T; Hoercher KJ; Howard MW; Takagaki M; Doi K; Fukamachi K
    Circulation; 2002 Sep; 106(12 Suppl 1):I198-202. PubMed ID: 12354733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a pulsatile right ventricular assist device and continuous arteriovenous hemodialysis in a 57-year-old man with a pulsatile left ventricular assist device.
    Chen JM; Levin HR; Catanese KA; Sistino JJ; Landry DW; Rose EA; Oz MC
    J Heart Lung Transplant; 1995; 14(1 Pt 1):186-91. PubMed ID: 7727468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful conversion of TandemHeart left ventricular assist device to right ventricular assist device after implantation of a HeartMate XVE.
    Takagaki M; Wurzer C; Wade R; Lee R; Malaisrie SC; McCarthy PM; McGee EC
    Ann Thorac Surg; 2008 Nov; 86(5):1677-9. PubMed ID: 19049776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human clinical fitting study of the DexAide right ventricular assist device.
    Ootaki Y; Ootaki C; Massiello A; Horvath D; Chen JF; Mihaljevic T; Navia JL; Smedira NG; Golding LA; Fukamachi K
    Artif Organs; 2009 Jul; 33(7):558-61. PubMed ID: 19566734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technique for less invasive implantation of Heartmate II left ventricular assist device without median sternotomy.
    Anyanwu AC
    Semin Thorac Cardiovasc Surg; 2011; 23(3):241-4. PubMed ID: 22172362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device.
    Gregoric ID; Bruckner BA; Jacob L; Kar B; Cohn WE; La Francesca S; Frazier OH
    Ann Thorac Surg; 2008 May; 85(5):1646-9. PubMed ID: 18442556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year.
    Martin J; Friesewinkel O; Benk C; Sorg S; Schultz S; Beyersdorf F
    J Heart Lung Transplant; 2006 Apr; 25(4):384-90. PubMed ID: 16563965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative risk factors for mortality after biventricular assist device implantation.
    Zahr F; Ootaki Y; Starling RC; Smedira NG; Yamani M; Thuita L; Fukamachi K
    J Card Fail; 2008 Dec; 14(10):844-9. PubMed ID: 19041048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cadaver fitting study of the DexAide right ventricular assist device.
    Ootaki Y; Ootaki C; Kamohara K; Akiyama M; Cingoz F; Kopcak MW; Dessoffy R; Liu J; Massiello A; Horvath D; Chen JF; Zhou Q; Benefit S; Golding LA; Fukamachi K
    Artif Organs; 2007 Aug; 31(8):646-8. PubMed ID: 17651120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome.
    Schenk S; McCarthy PM; Blackstone EH; Feng J; Starling RC; Navia JL; Zhou L; Hoercher KJ; Smedira NG; Fukamachi K
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):447-54. PubMed ID: 16434277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right ventricular failure after left ventricular assist device implantation: the need for an implantable right ventricular assist device.
    Furukawa K; Motomura T; Nosé Y
    Artif Organs; 2005 May; 29(5):369-77. PubMed ID: 15854212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right ventricular assist device with membrane oxygenator support for right ventricular failure following implantable left ventricular assist device placement.
    Leidenfrost J; Prasad S; Itoh A; Lawrance CP; Bell JM; Silvestry SC
    Eur J Cardiothorac Surg; 2016 Jan; 49(1):73-7. PubMed ID: 25877948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients.
    Feller ED; Sorensen EN; Haddad M; Pierson RN; Johnson FL; Brown JM; Griffith BP
    Ann Thorac Surg; 2007 Mar; 83(3):1082-8. PubMed ID: 17307463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.